Abstract
Porphyria cutanea tarda (PCT) is the most common type of porphyria, presenting in middle-aged patients with a photodistributed vesiculobullous eruption, milia, and scars. Porphyria cutanea tarda occurs in relation to inhibition of uroporphyrinogen decarboxylase, a key enzyme in the heme biosynthesis pathway. A number of genetic and acquired factors increase susceptibility to PCT by reducing uroporphyrinogen decarboxylase activity. A handful of other vesiculobullous conditions may mimic PCT both clinically and histologically; therefore, both skin biopsy and laboratory evaluation are helpful in confirming the diagnosis. We report a case of PCT in the setting of cigarette usage and untreated hepatitis C infection.
Original language | English (US) |
---|---|
Article number | 11 |
Journal | Dermatology online journal |
Volume | 25 |
Issue number | 12 |
State | Published - Dec 2019 |
Keywords
- Hepatitis C
- Porphyria cutanea tarda
- Tobacco
- Treatment
ASJC Scopus subject areas
- Dermatology